retatrutide clinical trial stage π may be redefining obesity treatment. New data from TRIUMPH-1 showed: π₯ ~28% average weight loss over 80 weeks π₯ >30% weight loss in nearly half of participant #ObesityMedicine #Retatrutide #GLP1 #CardioMetabolic Tirzepatide vs. Retatrutide | AlphaMan
Description
These are generally mild to moderate and tend to subside as the body adjusts to the medication
For more information, please refer to our Treatment Complications page:
Studies have demonstrated that Liraglutide has neuroprotective effects on AD-like neurodegeneration induced by H 2 O 2 in human neuroblastoma cell line SH-SY5Y (185, 186), and protects against brain A accumulation by partially rescuing oxidative stress (146)
Keep refined sugars out of easy reach and stay hydrated, as thirst sometimes mimics hunger signals
The primary outcome occurred in 6.6% of the semaglutide group and 8.9% of the placebo group
